Advanced atypical lung carcinoid tumour successfully treated with carboplatin, etoposide and atezolizumab: A case report

Atypical carcinoid tumours are relatively rare among lung cancers. Surgery is regarded as standard treatment for localized cases, but there is little established evidence on treatment strategies for advanced cases. Moreover, the efficacy of immune checkpoint inhibitors for advanced carcinoid tumours...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Yoshihiro, Ijichi, Kayo, Koike, Ai, Nakamura, Satoshi, Takahata, Yuriko, Okamatsu, Yuki, Fujita, Akitaka, Kawakami, Satoru, Harada, Taishi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024153/
https://www.ncbi.nlm.nih.gov/pubmed/35475138
http://dx.doi.org/10.1002/rcr2.951
_version_ 1784690507789631488
author Yamamoto, Yoshihiro
Ijichi, Kayo
Koike, Ai
Nakamura, Satoshi
Takahata, Yuriko
Okamatsu, Yuki
Fujita, Akitaka
Kawakami, Satoru
Harada, Taishi
author_facet Yamamoto, Yoshihiro
Ijichi, Kayo
Koike, Ai
Nakamura, Satoshi
Takahata, Yuriko
Okamatsu, Yuki
Fujita, Akitaka
Kawakami, Satoru
Harada, Taishi
author_sort Yamamoto, Yoshihiro
collection PubMed
description Atypical carcinoid tumours are relatively rare among lung cancers. Surgery is regarded as standard treatment for localized cases, but there is little established evidence on treatment strategies for advanced cases. Moreover, the efficacy of immune checkpoint inhibitors for advanced carcinoid tumours is unclear. Here, we report a case of a patient with an atypical carcinoid tumour in whom successful disease control was achieved with the use of combined cytotoxic chemotherapy and immunotherapy.
format Online
Article
Text
id pubmed-9024153
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-90241532022-04-25 Advanced atypical lung carcinoid tumour successfully treated with carboplatin, etoposide and atezolizumab: A case report Yamamoto, Yoshihiro Ijichi, Kayo Koike, Ai Nakamura, Satoshi Takahata, Yuriko Okamatsu, Yuki Fujita, Akitaka Kawakami, Satoru Harada, Taishi Respirol Case Rep Case Reports Atypical carcinoid tumours are relatively rare among lung cancers. Surgery is regarded as standard treatment for localized cases, but there is little established evidence on treatment strategies for advanced cases. Moreover, the efficacy of immune checkpoint inhibitors for advanced carcinoid tumours is unclear. Here, we report a case of a patient with an atypical carcinoid tumour in whom successful disease control was achieved with the use of combined cytotoxic chemotherapy and immunotherapy. John Wiley & Sons, Ltd 2022-04-22 /pmc/articles/PMC9024153/ /pubmed/35475138 http://dx.doi.org/10.1002/rcr2.951 Text en © 2022 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Yamamoto, Yoshihiro
Ijichi, Kayo
Koike, Ai
Nakamura, Satoshi
Takahata, Yuriko
Okamatsu, Yuki
Fujita, Akitaka
Kawakami, Satoru
Harada, Taishi
Advanced atypical lung carcinoid tumour successfully treated with carboplatin, etoposide and atezolizumab: A case report
title Advanced atypical lung carcinoid tumour successfully treated with carboplatin, etoposide and atezolizumab: A case report
title_full Advanced atypical lung carcinoid tumour successfully treated with carboplatin, etoposide and atezolizumab: A case report
title_fullStr Advanced atypical lung carcinoid tumour successfully treated with carboplatin, etoposide and atezolizumab: A case report
title_full_unstemmed Advanced atypical lung carcinoid tumour successfully treated with carboplatin, etoposide and atezolizumab: A case report
title_short Advanced atypical lung carcinoid tumour successfully treated with carboplatin, etoposide and atezolizumab: A case report
title_sort advanced atypical lung carcinoid tumour successfully treated with carboplatin, etoposide and atezolizumab: a case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024153/
https://www.ncbi.nlm.nih.gov/pubmed/35475138
http://dx.doi.org/10.1002/rcr2.951
work_keys_str_mv AT yamamotoyoshihiro advancedatypicallungcarcinoidtumoursuccessfullytreatedwithcarboplatinetoposideandatezolizumabacasereport
AT ijichikayo advancedatypicallungcarcinoidtumoursuccessfullytreatedwithcarboplatinetoposideandatezolizumabacasereport
AT koikeai advancedatypicallungcarcinoidtumoursuccessfullytreatedwithcarboplatinetoposideandatezolizumabacasereport
AT nakamurasatoshi advancedatypicallungcarcinoidtumoursuccessfullytreatedwithcarboplatinetoposideandatezolizumabacasereport
AT takahatayuriko advancedatypicallungcarcinoidtumoursuccessfullytreatedwithcarboplatinetoposideandatezolizumabacasereport
AT okamatsuyuki advancedatypicallungcarcinoidtumoursuccessfullytreatedwithcarboplatinetoposideandatezolizumabacasereport
AT fujitaakitaka advancedatypicallungcarcinoidtumoursuccessfullytreatedwithcarboplatinetoposideandatezolizumabacasereport
AT kawakamisatoru advancedatypicallungcarcinoidtumoursuccessfullytreatedwithcarboplatinetoposideandatezolizumabacasereport
AT haradataishi advancedatypicallungcarcinoidtumoursuccessfullytreatedwithcarboplatinetoposideandatezolizumabacasereport

Ejemplares similares